AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial

AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.

Related Keywords

China ,India ,United Kingdom ,London ,City Of ,Bharat ,Sandy Douglas ,Andrew Freedman ,Cansino Biologics Inc ,University Of Oxford ,Cardiff University ,Astrazeneca Plc ,Bharat Biotech International Ltd ,Oxford Biomedical Research Centre ,Meissa Vaccines Inc ,Pfizer Inc ,Moderna Inc ,Oxford Jenner Institute ,Early Trial ,Zeneca Plc ,Meissa Vaccines ,Bharat Biotech International ,Cansino Biologics ,Jenner Institute ,Biomedical Research Centre ,Astrazeneca ,Nasal Spray ,Covid ,